BIOCON.NS Balance Sheet
Biocon Ltd.
Profit & Loss Balance Sheet Cash Flow
Balance Sheet · 8 years on file
(FY2018-19 to FY2025-26)
· fetched 2026-08-23 21:39
| Line item | FY2018-19 | FY2019-20 | FY2020-21 | FY2021-22 | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|---|---|---|---|
| Property, Plant and Equipment | N/A | N/A | N/A | N/A | ₹7,535.10 Cr. | ₹7,418.10 Cr. | ₹8,708.20 Cr. | ₹9,472.80 Cr. | PropertyPlantAndEquipment |
| Capital Work-in-Progress | N/A | N/A | N/A | N/A | ₹2,587.50 Cr. | ₹3,985.20 Cr. | ₹4,101.70 Cr. | ₹4,612.70 Cr. | CapitalWorkInProgress |
| Goodwill | N/A | N/A | N/A | N/A | ₹16,136.20 Cr. | ₹16,372.40 Cr. | ₹16,785.70 Cr. | ₹18,377.50 Cr. | Goodwill |
| Other Intangible Assets | N/A | N/A | N/A | N/A | ₹5,796.40 Cr. | ₹6,853.10 Cr. | ₹6,469.40 Cr. | ₹8,635.60 Cr. | OtherIntangibleAssets |
| Non-current Investments | N/A | N/A | N/A | N/A | ₹604.50 Cr. | ₹684.10 Cr. | ₹679.70 Cr. | ₹1,089.30 Cr. | NoncurrentInvestments |
| Other Non-current Assets | N/A | N/A | N/A | N/A | ₹652.40 Cr. | ₹840.90 Cr. | ₹846.30 Cr. | ₹714.40 Cr. | OtherNoncurrentAssets |
| Total Non-current Assets | N/A | N/A | N/A | N/A | ₹39,708.80 Cr. | ₹40,891.50 Cr. | ₹42,511.10 Cr. | ₹46,470.80 Cr. | NoncurrentAssets |
| Inventories | N/A | N/A | N/A | N/A | ₹4,243.70 Cr. | ₹4,943.90 Cr. | ₹4,931.10 Cr. | ₹6,085.70 Cr. | Inventories |
| Trade Receivables | N/A | N/A | N/A | N/A | ₹3,573.20 Cr. | ₹6,230.60 Cr. | ₹5,487.90 Cr. | ₹5,986.80 Cr. | TradeReceivablesCurrent |
| Cash and Cash Equivalents | N/A | N/A | N/A | N/A | ₹1,323.50 Cr. | ₹1,233.60 Cr. | ₹3,227.10 Cr. | ₹2,416.50 Cr. | CashAndCashEquivalents |
| Current Investments | N/A | N/A | N/A | N/A | ₹1,326.50 Cr. | ₹315.60 Cr. | ₹447.30 Cr. | ₹689.80 Cr. | CurrentInvestments |
| Other Current Assets | N/A | N/A | N/A | N/A | ₹588.00 Cr. | ₹715.10 Cr. | ₹0.00 Cr. | ₹887.10 Cr. | OtherCurrentAssets |
| Total Current Assets | N/A | N/A | N/A | N/A | ₹12,334.00 Cr. | ₹15,179.20 Cr. | ₹16,286.20 Cr. | ₹17,179.80 Cr. | CurrentAssets |
| Total Assets | N/A | N/A | N/A | N/A | ₹52,042.80 Cr. | ₹56,070.70 Cr. | ₹58,797.30 Cr. | ₹63,650.60 Cr. | Assets |
| Equity Share Capital | N/A | N/A | N/A | N/A | ₹600.30 Cr. | ₹600.30 Cr. | ₹600.30 Cr. | ₹810.50 Cr. | EquityShareCapital |
| Other Equity | N/A | N/A | N/A | N/A | ₹17,266.60 Cr. | ₹19,183.40 Cr. | ₹21,043.70 Cr. | ₹33,221.30 Cr. | OtherEquity |
| Equity Attributable to Owners | N/A | N/A | N/A | N/A | ₹17,866.90 Cr. | ₹19,783.70 Cr. | ₹21,644.00 Cr. | ₹34,031.80 Cr. | EquityAttributableToOwnersOfParent |
| Non-controlling Interests | N/A | N/A | N/A | N/A | ₹4,621.90 Cr. | ₹5,491.10 Cr. | ₹6,068.50 Cr. | ₹2,589.70 Cr. | NonControllingInterest |
| Total Equity | N/A | N/A | N/A | N/A | ₹22,488.80 Cr. | ₹25,274.80 Cr. | ₹27,712.50 Cr. | ₹36,621.50 Cr. | Equity |
| Long-term Borrowings | N/A | N/A | N/A | N/A | ₹15,290.50 Cr. | ₹12,932.40 Cr. | ₹12,405.40 Cr. | ₹10,746.30 Cr. | BorrowingsNoncurrent |
| Total Non-current Liabilities | N/A | N/A | N/A | N/A | ₹21,043.30 Cr. | ₹15,437.10 Cr. | ₹16,751.00 Cr. | ₹12,959.90 Cr. | NoncurrentLiabilities |
| Short-term Borrowings | N/A | N/A | N/A | N/A | ₹2,480.20 Cr. | ₹2,797.20 Cr. | ₹5,350.10 Cr. | ₹4,078.40 Cr. | BorrowingsCurrent |
| Trade Payables | N/A | N/A | N/A | N/A | ₹3,983.10 Cr. | ₹6,272.00 Cr. | ₹6,548.70 Cr. | ₹6,772.10 Cr. | TradePayablesCurrent |
| Other Current Liabilities | N/A | N/A | N/A | N/A | ₹1,109.40 Cr. | ₹776.80 Cr. | ₹1,024.80 Cr. | ₹1,260.30 Cr. | OtherCurrentLiabilities |
| Total Current Liabilities | N/A | N/A | N/A | N/A | ₹8,510.70 Cr. | ₹15,358.80 Cr. | ₹14,333.80 Cr. | ₹14,069.20 Cr. | CurrentLiabilities |
| Total Equity and Liabilities | N/A | N/A | N/A | N/A | ₹52,042.80 Cr. | ₹56,070.70 Cr. | ₹58,797.30 Cr. | ₹63,650.60 Cr. | EquityAndLiabilities |
Every figure above is the exact value of the named XBRL element from BIOCON.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).